Tape-strip profiling identifies unique immune and lipid dysregulation in patients with seborrheic dermatitis
Benjamin Ungar, Meredith Manson, Madeline Kim, Digpal Singh Gour, Panipak Temboonnark, Ragasruti Metukuru, Joel Corrêa da Rosa, Yeriel Estrada, Jesús Gay-Mimbrera, Pedro Jesús Gómez‐Arias, Juan Ruano, Avner Shemer, Diane Hanna, Patrick Burnett, Emma Guttman‐Yassky
Abstract
BACKGROUND: Seborrheic dermatitis (SD) is a common, chronic inflammatory skin disease with limited understanding of its pathophysiology. Molecular profiling has been limited by invasiveness of sampling methods. OBJECTIVE: To analyze the molecular skin profile of adult patients with SD using tape strips. METHODS: Tape-strips obtained from facial lesions of 26 adult SD patients and 18 demographically matched healthy controls were evaluated with RNA sequencing. RESULTS: SD molecular skin fingerprint was characterized by strong and significant upregulation of interleukin (IL)23/T-helper (Th)17 and Th22 (i.e. IL23A, IL22, PI3, LL37, S100A8, S100A12), some Th1 skewing (OASL, STAT1, CXCL9), and limited Th2 modulation. A parallel downregulation of barrier markers (CLDN1/8, FA2H, ELOVL3) was also observed. LIMITATIONS: Limited representation of mild and severe SD patients. CONCLUSION: These data deepen our understanding of SD suggesting that it has robust Th17/Th22, some Th1 skewing, and minimal Th2 activation, and associated skin barrier alterations. This provides rationale for novel immunomodulatory treatment approaches for SD patients targeting IL23/Th17 and/or Th22 pathways.